A neuroscientist talks about how to classify MDMA.
Read moreKetamine Abuse Potential
Human Consciousness
Central to his theory is the concept of hyperdimensionality — the intriguing possibility that our universe harbors more dimensions than the four we can perceive (three spatial dimensions and one of time).
Read morePodcast Interview with Dr. Jeremy Narby
Jeremy Narby is a renowned anthropologist, author, and advocate for indigenous knowledge systems, particularly in the Amazon. His influential book, The Cosmic Serpent: DNA and the Origins of Knowledge (1998), explores the parallels between shamanic visions and molecular biology, proposing a connection between indigenous knowledge and our scientific understanding of DNA.
He has conducted extensive fieldwork with indigenous communities in the Peruvian Amazon, advocating for their rights and the preservation of their traditional knowledge.
Read morePsychedelics and Chronic Pain
Doctors across the country are beginning to look beyond their prescription pads to explore new treatments for chronic pain management: psychedelics.
Read moreDid the Psychedelic Research Bubble Burst?
The psychedelic renaissance is now at a point of reckoning, and the extraordinary promise of these drugs to quickly and easily transform lives for the better is starting to look more like a fever dream.
Read moreAncient History of Psychedelics
Historical documents point to psychoactive substances being used for healing purposes, but this was just one small aspect of their use.
Instead, spirit medicines played a major role in building connections within communities, sacred rituals, palliative care, exploring consciousness, facilitating creativity and hedonism.
Click here for the full article.
Read more5-MeO-MiPT
The psychedelic start-up Mindstate Design Labs, announced the company received approval from the U.S. Food and Drug Administration and the European Medicine Agency to begin human clinical trials studying the compound 5-MeO-MiPT.
Psychonauts call 5-MeO-MiPT “moxy.” Mindstate chose to develop the substance because 5-MeO-MiPT is “a psychedelic tofu,” according to DiNardo: Just as tofu takes on the flavors of any dish it’s put in, the drug takes on the properties of the other drugs with which it’s administered.
Risks with Psychedelics
Researchers should anticipate and track adverse effects in psychedelics research, a group of Maryland-based scientists argue in a paper recently published in Psychedelic Medicine.
For years, the field has been focused on the potential benefits of psychedelics, but the scientists argue that it’s time to pay more attention to understanding the risks.
Group Psychedelic Experiences and Success
Adverse Effects
This research study looks at the adverse effects in studies of psychedelics and MDMA.
Read more